Specific therapy using integrin ligands for treating cancer

Details for Australian Patent Application No. 2007207465 (hide)

Owner Merck Patent GmbH

Inventors Goodman, Simon; Harstrick, Andreas; Nippgen, Johannes; Grell, Matthias; Grimm, Ulrike; Mikkelsen, Tom; Weller, Michael; Stupp, Roger; Picard, Martin Andreas

Agent Davies Collison Cave

Pub. Number AU-A-2007207465

PCT Pub. Number WO2007/084670

Priority 06000988.3 18.01.06 EP; 06001044.4 18.01.06 EP; 06015883.9 31.07.06 EP; 06006003.5 20.01.06 EP

Filing date 18 January 2007

Wipo publication date 26 July 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/4188 (2006.01)

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/084670 Priority application(s): WO2007/084670

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207472-System and method for applying reduced pressure to cell culture

2007207458-Process for forming a metallized sheet